Aroa Biosurgery Ltd (ARX)

Currency in AUD
0.57
-0.02(-3.39%)
Closed·
ARX Scorecard
Full Analysis
Net income is expected to grow this year
ARX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.570.59
52 wk Range
0.350.82
Key Statistics
Bid/Ask
0.57 / 0.58
Prev. Close
0.59
Open
0.59
Day's Range
0.57-0.59
52 wk Range
0.35-0.82
Volume
128.06K
Average Volume (3m)
230.4K
1-Year Change
-9.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ARX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.82
Upside
+44.59%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Aroa Biosurgery Ltd Company Profile

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Compare ARX to Peers and Sector

Metrics to compare
ARX
Peers
Sector
Relationship
P/E Ratio
−56.3x−2.8x−0.5x
PEG Ratio
−0.880.040.00
Price/Book
2.3x3.3x2.6x
Price / LTM Sales
2.5x9.3x3.2x
Upside (Analyst Target)
44.5%188.6%41.7%
Fair Value Upside
Unlock1.6%6.1%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.82
(+44.59% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
45.54M / --
EPS Revisions
Last 90 days

ARX Income Statement

People Also Watch

11.210
ACHR
+2.00%
47.430
RKLB
-1.45%
2.880
CWY
+1.05%
2.720
RMS
-2.86%
0.575
AUC
-3.36%

FAQ

What Stock Exchange Does Aroa Biosurgery Trade On?

Aroa Biosurgery is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Aroa Biosurgery?

The stock symbol for Aroa Biosurgery is "ARX."

What Is the Aroa Biosurgery Market Cap?

As of today, Aroa Biosurgery market cap is 196.67M.

What Is Aroa Biosurgery's Earnings Per Share (TTM)?

The Aroa Biosurgery EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is ARX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Aroa Biosurgery Stock Split?

Aroa Biosurgery has split 0 times.

How Many Employees Does Aroa Biosurgery Have?

Aroa Biosurgery has 0 employees.

What is the current trading status of Aroa Biosurgery (ARX)?

As of 26 Jul 2025, Aroa Biosurgery (ARX) is trading at a price of 0.57, with a previous close of 0.59. The stock has fluctuated within a day range of 0.57 to 0.59, while its 52-week range spans from 0.35 to 0.82.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.